We’re committed to advancing the clinical understanding of underlying disease activity and progression for the millions of people living with multiple sclerosis (MS) worldwide.
Multiple sclerosis (MS) is a disease of the central nervous system (CNS), which includes the brain, spinal cord and optic nerves. It is usually thought of as a single disease, but its course and symptoms vary from person to person.
MS is a chronic and debilitating disease in which the immune system abnormally attacks the insulation and support around the nerve cells (myelin sheath) in the brain, spinal cord and optic nerves, causing inflammation and consequent damage.
This damage severely affects the quality of life of patients, and they may experience various symptoms such as blurry vision, temporary loss of eyesight, feeling of tingling and numbness, muscle weakness, pain and imbalance, problems with movement and coordination, inability to focus and think, difficulty in holding urine, sexual dysfunction and frequent fatigue. Not all such symptoms are present in every patient but may vary from person to person. If left untreated the disease progresses, leading to permanent disability.
There is no cure for MS, however recent advancements have resulted in the development of new treatments that may substantially reduce disease activity and slow down progression.
It is very important that MS is diagnosed and treated as early as possible. Early treatment can slow disease progression, and may help patients lead a normal life during their productive years.
This information is intended for the general public. Please consult your doctor if you need more information.